{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,7]],"date-time":"2025-08-07T20:22:36Z","timestamp":1754598156090,"version":"3.37.3"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2023,12,13]],"date-time":"2023-12-13T00:00:00Z","timestamp":1702425600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,12,13]],"date-time":"2023-12-13T00:00:00Z","timestamp":1702425600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1007\/s00277-023-05568-w","type":"journal-article","created":{"date-parts":[[2023,12,13]],"date-time":"2023-12-13T08:02:19Z","timestamp":1702454539000},"page":"893-903","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Optimal dosage of rituximab for children with Burkitt lymphoma"],"prefix":"10.1007","volume":"103","author":[{"given":"Shuang","family":"Huang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ling","family":"Jin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yonghong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yaguang","family":"Peng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanlong","family":"Duan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1484-9131","authenticated-orcid":false,"given":"Huyong","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,12,13]]},"reference":[{"key":"5568_CR1","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1200\/JCO.1991.9.1.123","volume":"9","author":"C Patte","year":"1991","unstructured":"Patte C, Philip T, Rodary C, Zucker JM, Gerrard M, Behrendt H et al (1991) High survival rate in advanced stage B-cell lymphomas and leukemias without CNS involvement with a short intensive poly chemotherapy: results from the French Pediatric Oncology Society of a randomized trial of 216 children. J Clin Oncol 9:123\u2013132. https:\/\/doi.org\/10.1200\/JCO.1991.9.1.123","journal-title":"J Clin Oncol"},{"key":"5568_CR2","doi-asserted-by":"publisher","first-page":"3370","DOI":"10.1182\/blood.v97.11.3370","volume":"97","author":"C Patte","year":"2001","unstructured":"Patte C, Auperin A, Michon J, Behrendt H, Leverger G, Frappaz D et al (2001) The Soci\u00e9t\u00e9 Fran\u00e7aise d\u2019Oncologie P\u00e9diatrique LMB89 protocol: highly effective multiagent chemotherapy tailored to the tumor burden and initial response in 561 unselected children with B-cell lymphomas and L3 leukemia. Blood 97:3370\u20133379. https:\/\/doi.org\/10.1182\/blood.v97.11.3370","journal-title":"Blood"},{"key":"5568_CR3","doi-asserted-by":"publisher","first-page":"2736","DOI":"10.1182\/blood-2006-07-036665","volume":"109","author":"MS Cairo","year":"2006","unstructured":"Cairo MS, Gerrard M, Sposto R, Auperin A, Pinkerton CR, Michon J (2006) Results of a randomized international study of high-risk central nervous system B non-Hodgkin lymphoma and B acute lymphoblastic leukaemia in children and adolescents. Blood 109:2736\u20132743. https:\/\/doi.org\/10.1182\/blood-2006-07-036665","journal-title":"Blood"},{"key":"5568_CR4","doi-asserted-by":"publisher","first-page":"10507","DOI":"10.1200\/JCO.2016.34.15_suppl.10507","volume":"34","author":"CV Minard","year":"2016","unstructured":"Minard CV, Auperin A, Pillon M, Burke A, Anderson JR, Donald A et al (2016) Results of the randomized intergroup trial Inter-B-NHL Ritux 2010 for children and adolescents with high-risk B-cell non-Hodgkin lymphoma (B-NHL) and mature acute leukemia (B-AL): evaluation of Rituximab (R) efficacy in addition to standard LMB chemotherapy (CT) regimen. J Clin Oncol 34:10507. https:\/\/doi.org\/10.1200\/JCO.2016.34.15_suppl.10507","journal-title":"J Clin Oncol"},{"key":"5568_CR5","doi-asserted-by":"publisher","first-page":"810","DOI":"10.3324\/haematol.2014.121434","volume":"100","author":"A Jourdain","year":"2015","unstructured":"Jourdain A, Auperin A, Minard-Colin V, Aladjidi N, Zsiros J, Coze C (2015) Outcome of and prognostic factors for relapse in children and adolescents with mature B-cell lymphoma and leukemia treated in three consecutive prospective \u201cLymphomes Malins B\u201d protocols. A Societe Francaise des Cancers de l\u2019Enfant study. Haematologica 100:810\u2013817. https:\/\/doi.org\/10.3324\/haematol.2014.121434","journal-title":"Haematologica"},{"key":"5568_CR6","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1111\/bjh.15491","volume":"182","author":"M Cairo","year":"2018","unstructured":"Cairo M, Auperin A, Perkins SL, Pinkerton R, Harrison L, Goldman S et al (2018) Overall survival of children and adolescents with mature B cell non-Hodgkin lymphoma who had refractory or relapsed disease during or after treatment with FAB\/LMB 96: a report from the FAB\/LMB 96 study group. Br J Haematol 182:859\u2013869. https:\/\/doi.org\/10.1111\/bjh.15491","journal-title":"Br J Haematol"},{"key":"5568_CR7","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3321\/j.issn:0578-1310.2008.03.012","volume":"46","author":"YH Zhang","year":"2008","unstructured":"Zhang YH, Duan YL, Yang J, Jin L, Zhou CJ, Gao ZF (2008) Clinical study in 40 Burkitt and Burkitt-like pediatric lymphoma (in Chinese). Chin Pediatric J 46:209\u2013214. https:\/\/doi.org\/10.3321\/j.issn:0578-1310.2008.03.012","journal-title":"Chin Pediatric J"},{"key":"5568_CR8","doi-asserted-by":"publisher","first-page":"2112","DOI":"10.1200\/JCO.2014.59.7203","volume":"33","author":"A Rosolen","year":"2015","unstructured":"Rosolen A, Perkins SL, Pinkerton CR et al (2015) Revised international pediatric non\u2014Hodgkin lymphoma staging system. J Clin Oncol 33:2112\u20132118","journal-title":"J Clin Oncol"},{"issue":"18","key":"5568_CR9","doi-asserted-by":"publisher","first-page":"2106","DOI":"10.1200\/JCO.2014.59.0745","volume":"33","author":"JT Sandlund","year":"2015","unstructured":"Sandlund JT, Guillerman RP, Perkins SL et al (2015) International pediatric non-Hodgkin lymphoma response criteria. J Clin Oncol 33(18):2106\u20132111","journal-title":"J Clin Oncol"},{"key":"5568_CR10","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1111\/bjh.15520","volume":"185","author":"J Kimble Frazer","year":"2019","unstructured":"Kimble Frazer J, Li KJ, Galardy PJ, Perkins SL, Auperin A, Cairo MS et al (2019) Excellent outcomes in children and adolescents with CNS+ Burkitt lymphoma or other mature B-NHL using only intrathecal and systemic chemo immunotherapy: results from FAB\/LMB96 and COG ANHL01P1. Br J Haematol 185:374\u2013377. https:\/\/doi.org\/10.1111\/bjh.15520","journal-title":"Br J Haematol"},{"key":"5568_CR11","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1182\/blood-2004-03-0973.17","volume":"105","author":"W Woessmann","year":"2005","unstructured":"Woessmann W, Seidemann K, Mann G, Martin Z, Birgit B, Ilske O et al (2005) The impact of the methotrexate administration schedule and dose in the treatment of children and adolescents with B-cell neoplasms: a report of the BFM Group Study NHL-BFM95. Blood 105:948\u2013958. https:\/\/doi.org\/10.1182\/blood-2004-03-0973.17","journal-title":"Blood"},{"key":"5568_CR12","doi-asserted-by":"publisher","first-page":"933","DOI":"10.3321\/j.issn.1000-467X.2004.08.015","volume":"23","author":"XF Sun","year":"2004","unstructured":"Sun XF, Sun YS, Liu DG, Jiang WQ, He YQ, Lin TY et al (2004) Copmaring CHOP CHOP+ HD-MTX, and BFM-90 regimens in the survival rate of children and adolescents (in Chinese). Chin Cancer J 23:933\u2013938. https:\/\/doi.org\/10.3321\/j.issn.1000-467X.2004.08.015","journal-title":"Chin Cancer J"},{"issue":"23","key":"5568_CR13","doi-asserted-by":"publisher","first-page":"2207","DOI":"10.1056\/NEJMoa1915315","volume":"382","author":"V Minard-Colin","year":"2020","unstructured":"Minard-Colin V, Aup\u00e9rin A, Pillon M (2020) Rituximab for high-risk, mature B-cell non-Hodgkin\u2019s lymphoma in children. N Engl J Med 382(23):2207\u20132219. https:\/\/doi.org\/10.1056\/NEJMoa1915315","journal-title":"N Engl J Med"},{"key":"5568_CR14","doi-asserted-by":"publisher","first-page":"605","DOI":"10.3760\/cma.j.issn.0578-1310.2018.08.010","volume":"56","author":"M Zhang","year":"2018","unstructured":"Zhang M, Jing L, Yang J, Duan YL, Huang S, Zhang YH et al (2018) The clinical characteristics and treatment outcome of 186 pediatric Burkitt\u2019s lymphoma (in Chinese). Chin Pediatric J 56:605\u2013610. https:\/\/doi.org\/10.3760\/cma.j.issn.0578-1310.2018.08.010","journal-title":"Chin Pediatric J"},{"key":"5568_CR15","doi-asserted-by":"publisher","first-page":"748","DOI":"10.3760\/cma.j.issn.0578-1310.2017.10.007","volume":"55","author":"S Huang","year":"2017","unstructured":"Huang S, Jin L, Yang J, Duan YL, Zhang M, Zhang YH et al (2017) Clinical pathological characteristics and treatment outcome of 19 relapsed Burkitt\u2019s lymphoma (in Chinese). Chin Pediatric J 55:748\u2013753. https:\/\/doi.org\/10.3760\/cma.j.issn.0578-1310.2017.10.007","journal-title":"Chin Pediatric J"},{"key":"5568_CR16","doi-asserted-by":"publisher","unstructured":"Shuang H, Ling J, Jing Y (2021) Treatment outcome in children with central nervous system-positive Burkitt lymphoma using only intrathecal and systemic chemotherapy combined with Rituximab: single-center experience from Beijing. Chin Med J (Engl). https:\/\/doi.org\/10.1097\/CM9.0000000000001386","DOI":"10.1097\/CM9.0000000000001386"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-023-05568-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00277-023-05568-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-023-05568-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,17]],"date-time":"2024-02-17T11:17:09Z","timestamp":1708168629000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00277-023-05568-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,13]]},"references-count":16,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,3]]}},"alternative-id":["5568"],"URL":"https:\/\/doi.org\/10.1007\/s00277-023-05568-w","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"type":"print","value":"0939-5555"},{"type":"electronic","value":"1432-0584"}],"subject":[],"published":{"date-parts":[[2023,12,13]]},"assertion":[{"value":"1 August 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 November 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 December 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Ethics Committee of Beijing Children\u2019s Hospital (IEC-C008-A08-V.05.1).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All patients signed informed consent sheets and consented to the publication of their anonymized data in this article.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Shuang Huang, Ling Jin, Meng Zhang, Yonghong Zhang, and Yanlong Duan have master\u2019s degrees. Yaguang Peng and Huyong Zheng have doctor\u2019s degrees.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Author highest academic degrees"}}]}}